117 related articles for article (PubMed ID: 28948859)
1. Whole-Body Distribution of Leukemia and Functional Total Marrow Irradiation Based on FLT-PET and Dual-Energy CT.
Magome T; Froelich J; Holtan SG; Takahashi Y; Verneris MR; Brown K; Dusenbery K; Wong J; Hui SK
Mol Imaging; 2017; 16():1536012117732203. PubMed ID: 28948859
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Functional Marrow Irradiation Based on Skeletal Marrow Composition Obtained Using Dual-Energy Computed Tomography.
Magome T; Froelich J; Takahashi Y; Arentsen L; Holtan S; Verneris MR; Brown K; Haga A; Nakagawa K; Holter Chakrabarty JL; Giebel S; Wong J; Dusenbery K; Storme G; Hui SK
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):679-87. PubMed ID: 27681765
[TBL] [Abstract][Full Text] [Related]
3. Mapping Radiation Injury and Recovery in Bone Marrow Using 18F-FLT PET/CT and USPIO MRI in a Rat Model.
Rendon DA; Kotedia K; Afshar SF; Punia JN; Sabek OM; Shirkey BA; Zawaski JA; Gaber MW
J Nucl Med; 2016 Feb; 57(2):266-71. PubMed ID: 26315835
[TBL] [Abstract][Full Text] [Related]
4. Distribution Atlas of Proliferating Bone Marrow in Non-Small Cell Lung Cancer Patients Measured by FLT-PET/CT Imaging, With Potential Applicability in Radiation Therapy Planning.
Campbell BA; Callahan J; Bressel M; Simoens N; Everitt S; Hofman MS; Hicks RJ; Burbury K; MacManus M
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1035-1043. PubMed ID: 26194679
[TBL] [Abstract][Full Text] [Related]
5. Effect of Platinum-Based Chemoradiotherapy on Cellular Proliferation in Bone Marrow and Spleen, Estimated by (18)F-FLT PET/CT in Patients with Locally Advanced Non-Small Cell Lung Cancer.
Leimgruber A; Möller A; Everitt SJ; Chabrot M; Ball DL; Solomon B; MacManus M; Hicks RJ
J Nucl Med; 2014 Jul; 55(7):1075-80. PubMed ID: 24868108
[TBL] [Abstract][Full Text] [Related]
6. 3'-deoxy-3'-[¹⁸F]fluorothymidine PET quantification of bone marrow response to radiation dose.
McGuire SM; Menda Y; Boles Ponto LL; Gross B; Buatti J; Bayouth JE
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):888-93. PubMed ID: 21300484
[TBL] [Abstract][Full Text] [Related]
7. Effect of radiotherapy and chemotherapy on bone marrow activity: a 18F-FLT-PET study.
Agool A; Slart RH; Thorp KK; Glaudemans AW; Cobben DC; Been LB; Burlage FR; Elsinga PH; Dierckx RA; Vellenga E; Holter JL
Nucl Med Commun; 2011 Jan; 32(1):17-22. PubMed ID: 21166089
[TBL] [Abstract][Full Text] [Related]
8. Spatial mapping of functional pelvic bone marrow using FLT PET.
McGuire SM; Menda Y; Ponto LLB; Gross B; TenNapel M; Smith BJ; Bayouth JE
J Appl Clin Med Phys; 2014 Jul; 15(4):129–136. PubMed ID: 25207403
[TBL] [Abstract][Full Text] [Related]
9. Assessing Bone Marrow Activity in Patients with Myelofibrosis: Results of a Pilot Study of
Vercellino L; Ouvrier MJ; Barré E; Cassinat B; de Beco V; Dosquet C; Chevret S; Meignin V; Chomienne C; Toubert ME; Merlet P; Kiladjian JJ
J Nucl Med; 2017 Oct; 58(10):1603-1608. PubMed ID: 28360204
[TBL] [Abstract][Full Text] [Related]
10. Targeted total marrow irradiation using three-dimensional image-guided tomographic intensity-modulated radiation therapy: an alternative to standard total body irradiation.
Wong JY; Liu A; Schultheiss T; Popplewell L; Stein A; Rosenthal J; Essensten M; Forman S; Somlo G
Biol Blood Marrow Transplant; 2006 Mar; 12(3):306-15. PubMed ID: 16503500
[TBL] [Abstract][Full Text] [Related]
11. 18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging.
Zhou M; Wang C; Hu S; Zhang Y; Yao Z; Li J; Guo W; Zhang Y
Nucl Med Commun; 2013 Jul; 34(7):694-700. PubMed ID: 23604223
[TBL] [Abstract][Full Text] [Related]
12. A Novel Application of [18F]Fluorothymidine-PET ([18F]FLT-PET) in Clinical Practice to Quantify Regional Bone Marrow Function in a Patient With Treatment-Induced Cytopenias and to Guide "Marrow-Sparing" Radiotherapy.
Campbell BA; Hofman MS; Prince HM
Clin Nucl Med; 2019 Nov; 44(11):e624-e626. PubMed ID: 31584492
[TBL] [Abstract][Full Text] [Related]
13. First demonstration of leukemia imaging with the proliferation marker 18F-fluorodeoxythymidine.
Buck AK; Bommer M; Juweid ME; Glatting G; Stilgenbauer S; Mottaghy FM; Schulz M; Kull T; Bunjes D; Möller P; Döhner H; Reske SN
J Nucl Med; 2008 Nov; 49(11):1756-62. PubMed ID: 18927328
[TBL] [Abstract][Full Text] [Related]
14. A methodology for incorporating functional bone marrow sparing in IMRT planning for pelvic radiation therapy.
McGuire SM; Menda Y; Ponto LL; Gross B; Juweid M; Bayouth JE
Radiother Oncol; 2011 Apr; 99(1):49-54. PubMed ID: 21397965
[TBL] [Abstract][Full Text] [Related]
15. Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus.
Han D; Yu J; Yu Y; Zhang G; Zhong X; Lu J; Yin Y; Fu Z; Mu D; Zhang B; He W; Huo Z; Liu X; Kong L; Zhao S; Sun X
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1235-41. PubMed ID: 19910143
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S
Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
[TBL] [Abstract][Full Text] [Related]
17. Measuring tumor cell proliferation with 18F-FLT PET during radiotherapy of esophageal squamous cell carcinoma: a pilot clinical study.
Yue J; Chen L; Cabrera AR; Sun X; Zhao S; Zheng F; Han A; Zheng J; Teng X; Ma L; Ma Y; Han D; Zhao X; Mu D; Yu J; Li Y
J Nucl Med; 2010 Apr; 51(4):528-34. PubMed ID: 20237030
[TBL] [Abstract][Full Text] [Related]
18. Whole-body biodistribution of 3'-deoxy-3'-[(18) f]fluorothymidine ((18) FLT) in healthy adult cats.
Rowe JA; Morandi F; Wall JS; Akula M; Kennel SJ; Osborne D; Martin EB; Galyon GD; Long MJ; Stuckey AC; LeBlanc AK
Vet Radiol Ultrasound; 2013; 54(3):299-306. PubMed ID: 23464567
[TBL] [Abstract][Full Text] [Related]
19. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
20. Imaging proliferation in human leukemia-tumor bearing mice with (18)F-FLT: Comparison with (18)F-FDG PET.
Lu L; Jiang L; Guan H; Gao Y; Lu H
Hell J Nucl Med; 2012; 15(3):206-9. PubMed ID: 23106052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
